54 results
DEFM14A
INBX
Inhibrx Biosciences, Inc.
26 Apr 24
Proxy related to merger
4:06pm
Termination”), the executive would be entitled to: (i) a lump sum cash payment equal to 1.5X the sum of base salary and target bonus; (ii) 18 months … target bonus remain unchanged from those in effect as of the date of this proxy statement;
Each named executive officer’s Company equity awards
8-K
EX-99.1
INBX
Inhibrx Biosciences, Inc.
28 Feb 24
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
9:12am
expansion of the Company’s clinical team, as well as the issuance of additional stock options and the expansion of the bonus eligibility pool during … team, as well as increased expense related to additional stock option grants to employees and the expansion of the bonus eligibility pool in the current
DEFA14A
INBX
Inhibrx Biosciences, Inc.
23 Jan 24
Additional proxy soliciting materials
5:25pm
this affect the payment of my bonus for 2023?
A7: This will not impact the payment of bonuses for 2023 performance. We still plan to pay those in February … or March 2024, consistent with prior years, and in accordance with the terms of the bonus plan.
Q8: Which Company will provide my employee benefits
DEFA14A
INBX
Inhibrx Biosciences, Inc.
23 Jan 24
Additional proxy soliciting materials
6:38am
or not subject to ERISA); and (iv) each other benefit plan, policy, program, agreement or arrangement, including but not limited to any bonus … letter, individual independent contractor or consulting, pension, profit-sharing, retirement, insurance, stock bonus, stock purchase, stock option
8-K
EX-2.1
umenmsdz
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
8-K
EX-2.2
blllje8cg8aove1pq
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
8-K
EX-99.1
i4vnz4ctycbd xe
9 Nov 23
Inhibrx Reports Third Quarter 2023 Financial Results
4:03pm
8-K
EX-99.1
3t7ruj t0ncw
7 Aug 23
Inhibrx Reports Second Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
c331ioa7dkq od
8 May 23
Inhibrx Reports First Quarter 2023 Financial Results
4:05pm